Results 161 to 170 of about 95,214 (265)

Association between Over- and Under-Replacement with Thyroid Hormone and Incident Heart Failure. [PDF]

J Clin Endocrinol Metab
Evron J, Moretti B, Evans R, Burns J, Hummel SL, Esfandiari NH, Hawley ST, Haymart MR, Papaleontiou M.   +8 more
europepmc   +1 more source

Hypersscretion of ACTH growth hormone and prolactin in a patient with pituitary adenoma [PDF]

, 1978
Fink, R., Müller, O. A., Scriba, Peter Christian, Werder, Klaus von   +3 more
core   +1 more source

Modified cytoskeletal and extracellular matrix composition in the canine testis after long‐acting gonadotropin‐releasing hormone agonist deslorelin treatment

Andrology, EarlyView.
Abstract Background Long‐acting gonadotropin‐releasing hormone (GnRH) agonists are commonly used for fertility control in male dogs. Their effect on testicular histomorphology has not been clarified. Objectives To elucidate the mechanisms underlying androgen withdrawal in response to long‐acting GnRH agonist deslorelin 4.7 mg treatment on testicular ...
Aykut Gram, Murat Abay, Duygu Yaman Gram, Narin Liman, Linda Müller, Orsolya Balogh   +5 more
wiley   +1 more source

When Hormones Shape the Mind: Neuropsychiatric Manifestations in a Patient With Congenital Adrenal Hyperplasia and Genital Ambiguity. [PDF]

Cureus
Galindo D, Gonzalez C, Osorno D, Baños Pabon LC.   +3 more
europepmc   +1 more source

Current gynaecological management of women and girls with bleeding disorders in the United Kingdom: A UKHCDO haemophilia treatment centre survey and evaluation of real‐world clinical practice for the British Journal of Haematology

British Journal of Haematology, EarlyView.
Summary Girls and women with bleeding disorders (GWBD) comprise more than half of all registered patients with bleeding disorders in the UK National Haemophilia Database. The gynaecological care of GWBD, until recently, has not been prioritised despite high health burdens, where four of every five patients experience heavy menstrual bleeding (HMB).
Laura Knox, Imogen Swart‐Rimmer, Naim Rahimi, Callum Harris, Lugain Abdalla, Gary Benson, Clare Brown, Helen Campbell, Ana Carvalhosa, Justin T. Clarke, Sarah Garside, Claire Lentaigne, Jayna Mistry, Priyanka Raheja, Cora Warren, Rezan Abdul‐Kadir, Gill Lowe, Nicola Curry   +17 more
wiley   +1 more source

Challenging the principle of "No presumption of advantage" with a focus on testosterone and gender eligibility in sports. [PDF]

Front Sports Act Living
Atherton PJ, Hu K, Jones-Freeman B, Cheung AS, Costa RJS, Eynon N, Seto JT, Moesgaard L, Hostrup M, Lima G, Pitsiladis Y.   +10 more
europepmc   +1 more source

Beyond affirmation: Lessons from Tavistock —A psychoanalytic critique of identity certainty and institutional defence

British Journal of Psychotherapy, EarlyView.
Abstract This paper offers a psychoanalytic critique of the affirmation model in gender identity care, drawing on clinical experience from the Tavistock Gender Identity Development Service (GIDS). It argues that institutional and therapeutic responses to gender distress in young people are increasingly shaped by pressures to affirm rather than to ...
Marcus Evans
wiley   +1 more source

Endocrine system disturbances in children with inherited metabolic diseases: a narrative review. [PDF]

Front Endocrinol (Lausanne)
Tagi VM, Fiori L, Montanari C, Tonduti D, Ferrario M, Gambino M, Greco IP, Cecchini A, Calcaterra V, Zuccotti G, Verduci E.   +10 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

No more sleepless nights in perimenopause-an open-label, randomized, parallel-group, active controlled intervention study in perimenopausal women with vasomotor symptoms and insomnia to investigate the efficacy of hormone replacement therapy and cognitive behavioral therapy for the treatment of insomnia: study protocol. [PDF]

Trials
Pavicic E, Stute P, Rudzik F, Urech A, Lozza-Fiacco S.   +4 more
europepmc   +1 more source